Zina Patel, M.Eng.
About Zina Patel, M.Eng.
Zina Patel, M.Eng., is a Scientist at Bristol Myers Squibb with a background in Chemical & Biochemical Engineering and experience in Analytical Research & Development.
Current Position at Bristol Myers Squibb
Zina Patel, M.Eng., is currently employed as a Scientist at Bristol Myers Squibb. Since joining the company in August 2021, she has been a part of the Discovery Pharmaceutics department. Her role involves contributing to the research and development efforts within the company, leveraging her extensive background in chemical and biochemical engineering.
Previous Experience at Amneal Pharmaceuticals
Before her current position, Zina Patel worked at Amneal Pharmaceuticals. She started as an Analytical R&D Intern in Piscataway, New Jersey, for three months in 2017. Later, she advanced to the role of Scientist II in the Analytical Research & Development (AR&D) department, where she served from 2018 to 2021. During her three-year tenure, she gained significant experience in analytical research and development within the pharmaceutical industry.
Educational Background at Rutgers University
Zina Patel completed her undergraduate and graduate education at Rutgers University. She earned a Bachelor of Science in Chemical & Biochemical Engineering / Packaging Engineering between 2014 and 2018. Following this, she pursued and attained a Master of Engineering in Chemical & Biochemical Engineering from the Rutgers School of Engineering, specializing in Pharmaceutical Engineering, from 2019 to 2021.
Specialization in Chemical & Biochemical Engineering
Zina Patel specializes in Chemical & Biochemical Engineering with a focus on Pharmaceutical Engineering. Her expertise spans various aspects of chemical and biochemical processes, as evidenced by her academic background and professional roles in analytical research and development (AR&D). This specialized knowledge supports her contributions to the pharmaceutical industry, particularly within the Discovery Pharmaceutics department at Bristol Myers Squibb.